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Abstract
Calcium-phosphate levels have an effect on the vascular wall. Calcium is a cation 
in human body. It is has a crucial effect on intracellular and extracellular mecha-
nisms. Extracellular calcium levels are more than intracellular levels. In total serum, 
the calcium level is approximately 8.8–10.4. Parathormone and vitamin D regulate 
blood calcium levels. Phosphorus is more common than calcium in the human 
body. Most of the phosphorus is present in the skeletal system. Phosphorus level is 
approximately 2.5–4.5 mg/dl in blood. It is often observed calcification in cardiovas-
cular system in some diseases such as chronic renal failure due to increased calcium-
phosphate levels. While the calcification seems in tunica intima layer of the vessel 
in atherosclerotic disease, it seems in tunica media layer of vessel in chronic renal 
failure with high uremic level. Vascular calcification is due to arterial stiffness, ste-
nosis, and occlusion. Vascular and valvular calcifications are irreversible. Increased 
arterial stiffness destroys vascular compliance, causes left ventricular hypertrophy, 
and disrupts coronary perfusion. As a result, increased vascular calcification is 
associated with cardiovascular mortality.
Keywords: cardiovascular calcification, arterial stiffness, vascular compliance, 
hyperparathyroidism, hyperphosphatemia
1. Introduction
Cardiovascular pathologies are still one of the most serious diseases in the 
world and are also known to be an important reason of mortality and morbidity. 
Furthermore, they cause a significant burden on the health costs. The understand-
ing of pathophysiology of cardiovascular diseases has an important role for the 
treatment success. In this chapter, vascular calcification mechanism and its results 
will be discussed.
There are several reasons leading to vascular calcifications (Table 1). Vascular 
calcifications often occur in the advanced stage of the atherosclerosis [1]. In addi-
tion to this, these calcifications may also occur as a complication of metabolic 
disorders in the end stage of chronic renal failure. Calcium deposits accumulate in 
vascular tissues as a result of secondary hyperparathyroidism that occurs in chronic 
renal failure [2, 3]. Another cause of vascular calcifications is familial hypercho-
lesterolemia. Particularly severe aortic calcifications are seen in these patients [4]. 
Vascular calcifications associated with diabetes mellitus also affect the media and 
intima layer of vessels [5]. Hypertension is associated with calcifications in the 
abdominal aorta [6]. The other causes of vascular calcification include smoking 
[7], male gender [6], and older age [7]. Recently, it has been observed thanks to 
intravascular invasive images that the use of statins increases vascular calcifica-
tion. Despite the antilipidemic and anti-inflammatory effects of it, statins cause an 
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increased calcification in vascular tissue with an unknown mechanism. This effect 
is defined as the statin paradox [8].
2. Pathophysiology
Vascular smooth muscle cells (VSMCs) play an important role in the pathology 
of vascular calcifications. Vascular smooth muscle cells are of mesenchymal origin. 
These cells may turn into osteoblasts and chondrocytes under stress. Osteoblast-like 
cells that contain hydroxyapatite crystals appear in the extracellular matrix during 
vascular smooth muscle calcification. Subsequently, the number of osteochon-
drogenic cells increases, and calcification inhibitors are suppressed; an increased 
regulation of bone mineralization regulating genes and the release of calcified 
membrane-dependent carriers from smooth muscle cells in these calcifications are 
observed. In addition, intracellular phosphate concentration increases in osteoblast-
like cells due to developing hyperphosphatemia in chronic renal failure. Apoptosis 
in smooth muscle cells, oxidative stress, remodeling in extracellular matrix, and 
high levels of metalloproteinases increase vascular calcification, resulting in endo-
thelial dysfunction [9].
Vascular smooth muscle cells are the predominant cell type in the arterial wall. 
VSMCs are mainly composed of the medial layer of the blood vessels, which are 
subjected to mechanical stress and pressure of blood flow, and maintain vascular 
tone and resistance [10]. Calcium functions as a stimulator, and under physiological 
conditions, intracellular calcium is present in VSCMs to regulate many biophysical 
and biochemical processes [11]. Although the agents responsible for production of 
vasospasm have not yet been clearly identified, recently the molecular mechanisms 
involved in the development of vasospasm mainly based on experimental data in 
canine two-hemorrhage model are reviewed. The blood products after subarach-
noid hemorrhage most likely stimulate many cell membrane receptors to activate 
the tyrosine kinase pathway of WSCMs. The activation of the tyrosine kinase 
pathway is associated with continuous elevation of intracellular Ca++ levels and 
activation of mu-calpain. The increased intracellular Ca++ concentration stimulates 
Ca++/calmodulin and depends on myosin light-chain kinase to phosphorylate 
myosin light-chain continuously during vasospasms [12]. Cerebral vasospasm is the 
most frequent and troublesome complication after aneurysmal subarachnoid hem-
orrhage. Cerebral vasospasm is considered a treatable clinicopathological entity; it 
is still responsible for many deaths and serious disabilities among patients suffering 
from intracranial aneurysm rupture [13].
Causes of vascular calcification
• Atherosclerosis
• Chronic renal failure
• Familial hypercholesterolemia
• Diabetes mellitus
• Hypertension
• Smoking
• Male gender
• Older age
Table 1. 
The causes of vascular calcification.
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3. Classification
Vascular calcifications are divided into two subtypes (Figure 1). These are called 
intima and media calcifications according to the localization of calcification.
Intimal calcifications or the so-called atherosclerotic calcifications begin to 
occur in the presence of chronic inflammations and/or lipid accumulations. Lipid-
loaded calcifications in the intima cause intimal thickening and subsequent narrow-
ing of the lumen diameter.
Medial calcifications are characterized by concentric calcium deposits in the 
tunica media layer. Here, elastin lamellae occur between the smooth muscle cells 
and the elastin fibers. Medial calcifications cause loss of elasticity in the arteries, 
resulting in arterial stiffness [9].
4. Imaging methods
Various methods are used to visualize calcifications. Macrocalcifications can be 
seen in three ways:
1. Speckled: spotty calcification flecks, up to 50 μm diameters
2. Sheetlike fragments: linear or wide single focus of calcium, >2 mm in diameter
3. Diffuse: segments of continuous calcification, ≥5 mm in diameter
Imaging methods can be performed as noninvasive and invasive (Table 2).
4.1 Noninvasive methods
Computerized tomography (CT) is the gold standard for imaging calcifications. 
400 μm of calcification can be shown as 2D and 3D with the help of CT. However, 
the calcifications sometimes can be seen as more exaggerated than usual because 
of the absorption of high X-rays by neighboring tissues in CT imaging. This exag-
gerated image (artifact) may mask parts of calcification in the proximal region of 
the lesions. In this case, the artifact can be distinguished from the surrounding soft 
tissue with the help of magnetic resonance imaging (MRI). MRI is also superior 
to CT in differentiating multiple components including the coexistence of lipid 
accumulation, fibrotic tissue, and calcifications.
Microcalcifications can be detected by the use of positron emission tomography 
(PET) which is one of the other noninvasive methods. Early microcalcifications are 
shown using indirect gamma rays with the aid of 18F-sodium fluoride. With the use 
Figure 1. 
The classification of vascular calcification.
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of MRI or CT combined with PET, we can obtain more detailed information about 
the effects of calcifications, interactions with fibrotic tissue, and plaque geometry.
4.2 Invasive methods
In recent years, intravascular ultrasound (IVUS) has been widely used in the 
detection of vascular calcifications, and its success is 50% higher than CT imag-
ing. However, in the vessels with severe calcifications, they may not be able to 
adequately measure volume and wall thickness due to acoustic shadowing and 
insufficient penetration into macrocalcific deposits.
Optical coherence tomography (OCT) is an alternative modality using infrared 
ray. The specificity and sensitivity of this method is higher than other methods. 
OCT also identifies superficial calcifications in the vessels. In addition, in the case 
of acute plaque rupture, OCT detects spot calcifications in the areas of plaque near 
the lumen and the thinning of the vessel wall [14].
5. Clinical properties
The calcifications may occur in all anatomic structures of the cardiovascular 
system. Pericardial calcifications occur secondary to inflammation. Calcification of 
this type is usually asymptomatic; however, the clinical findings are observed when 
it causes constrictive pericarditis [15].
Myocardial calcifications are metastatic or dystrophic calcifications. Metastatic 
calcifications develop after impaired calcium metabolism due to chronic renal fail-
ure or hyperparathyroidism. Dystrophic calcifications develop as a result of myo-
cardial fibrosis, infections, sarcoidosis, and hemorrhagic events in the myocardium. 
The cell necrosis occurs in this pathology, resulting in myocardial damage. This type 
of calcification leads to local myocardial contraction disorder, diastolic dysfunction, 
arrhythmia, and eventually congestive heart failure [16].
Epidemiological studies have found a strong association between calcification 
and coronary artery-related event and mortality using coronary artery calcification 
scores. Cardiovascular prognosis and mortality can be predicted with these scoring. 
Calcifications have an important role in thrombotic complications of atherosclerosis. 
Progression in coronary artery calcification shows active atherosclerosis and high 
rupture risk in unstable plaques. On the other hand, calcifications in the coronary artery 
cause some problems in the invasive treatments. During percutaneous transluminal 
coronary angioplasty (PTCA), a high dilatation pressure is required due to calcific 
coronary artery structure. Technical difficulties also arise when adjusting the position 
The imaging methods for vascular calcification
Noninvasive methods
• Computerized tomography (CT)
• Magnetic resonance imaging (MRI)
• Positron emission tomography (PET)
Invasive methods
• Intravascular ultrasound (IVUS)
• Optical coherence tomography (OCT)
Table 2. 
The imaging methods for vascular calcifications.
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of the stent. As a result, coronary artery calcifications cause dissection, thrombosis, and 
restenosis during PTCA [17]. Another issue is that long-term prognosis of patients who 
underwent PTCA for moderate and severe coronary artery calcification is also poor [18].
Calcifications also affect heart valves. The annulus of the mitral valve is affected 
from this calcification, especially in female, elder patients and in case of chronic 
renal failure, radiotherapy applications. The pathophysiology of mitral annular 
calcification (MAC) is similar to that of atherosclerosis. Excessive MAC makes it 
difficult to perform balloon valvuloplasty and valve-sparing surgical procedures. 
On the other hand, in patients with MAC who underwent valve replacement, para-
valvular leakage, the circumflex coronary artery injury, arrhythmia, and patient 
artificial valve mismatch (because of the condition of small-size valve usage) may 
be observed [19]. During transcatheter mitral valve replacements, calcifications 
may lead to left ventricle outflow obstruction and paravalvular leakage [20].
Calcific aortic valve disease is the most common form of calcific valvular pathol-
ogy. When we look at the pathogenesis of this disease, the ectopic calcium nodules 
are located on the aortic surface of the aortic valve and in the aortic annulus. The 
incidence of calcific aortic valve increases with age. However, calcification of bicus-
pid valves may be seen at an early age. Risk factors are similar to other cardiovascu-
lar diseases. Calcifications can reduce the success of prosthetic aortic valve surgery 
[21]. In the late stages of valve replacement for calcific aortic valve stenosis, fistulas 
may develop between the left ventricle and the right atrium [22]. In transcatheter 
aortic valve implantations (TAVI), the degree of valve calcification is routinely 
evaluated by preoperative multi-slice CT. In this way, the information about the 
presence of asymmetric calcification is obtained before the procedure [23]. As a 
complication, cerebral emboli originating from calcific aortic valve stenosis may 
occur [24]. In addition, valve degeneration may occur secondary to calcification in 
patients undergoing valve replacement with bioprosthetic valve [25].
Excessive aortic valve calcification and metastatic calcifications due to chronic 
renal failure and hyperparathyroidism may affect the conduction system of the 
heart. Many arrhythmia types, from nodal rhythm to branch blocks, may be 
observed due to these calcifications [26–28].
Calcifications in the arcus and thoracic aorta cause aneurysm development, 
aortic occlusions, and distal embolization. These calcifications in the aortic wall 
also affect the success of endovascular stenting and surgical interventions [29]. It 
has been observed that the possibility of developing intermittent claudication is 
increased in the follow-up of patients with abdominal aortic calcification [30].
İntracranial artery calcification has been demonstrated to be correlated with isch-
emic stroke, cognitive decline, and other vascular events by accumulating evidence 
from both Western and Asian populations [31]. As atherosclerotic vasculopathy is a 
systemic process, vascular calcification may play a role in cerebrovascular events in 
both qualitative and quantitative calcium scoring with intracranial atherosclerosis 
and ischemic events [32]. On the other hand, some studies showed that ruptured 
intracranial aneurysms had a lower calcification fraction and lacked macrocalcifica-
tions than unruptured intracranial aneurysms [33]. Another study showed that 
arterial calcification correlated with white matter hyperintensities and lacunes [34].
Calcification is rarely seen in the venous system. Venous calcifications in the 
literature are mostly associated with the portal vein [35].
6. Treatment
Treatment of vascular calcifications is distributed over a wide range. Developing 
new medications and technical devices reconstruct our treatment modalities with 
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that disease. As is known, vascular calcifications are the major factor limiting 
endovascular treatment methods. One of the methods developed to overcome this 
problem is the peripheral intravascular lithotripsy (IVL) system. With this method, 
calcific lesions can be eliminated by applying pulsatile mechanical energy under 
fluoroscopy [36].
Obstructive disease of infra-inguinal arteries is treated with atherectomy 
methods. Various atherectomy devices have been developed for this method. Some 
of these are rotational, phoenix, directional, orbital, etc. The B-Laser atherectomy 
system is one of the new generation devices. This device is equipped with an 
optical fiber and circumferential designed blades for transmitting laser energy. 
Calcifications, fibrotic atherosclerotic plaques, and re-stenotic tissues are removed 
with the aspiration catheter added to the system [37].
There are several studies to improve medical treatment. Experimental animal 
studies have shown that angiotensin II receptor inhibitors prevent the vascular 
calcification due to hyperphosphatemia [38]. In another experimental animal study, 
the use of teniposide which inhibits DNA topoisomerase II in the treatment of 
cancer has been shown to prevent the development of vascular calcification [39]. 
Vitamin K II, added to the diet in chronic renal failure, acts on calcium hemostasis 
by preventing bone loss. Thus, it is shown that vitamin K II can prevent vascular 
calcification by adding it to the treatment regimen [40]. Another treatment modal-
ity is parathyroidectomy which is applied especially in vascular calcifications as a 
result of calcium and phosphate metabolism-related disorders [41].
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
7Vascular Calcifications
DOI: http://dx.doi.org/10.5772/intechopen.90287
[1] Boström K. Insıght into the 
mechanism of vascular calcification. 
The American Journal of Cardiology. 
2001;88:29E-22E
[2] Giachelli CM. Vascular calcification: 
In vitro evidence for the role of 
inorganic phosphate. Journal of the 
American Society of Nephrology. 
2003;14(Suppl 4):s300-s304
[3] Thomson C. Vascular calcification in 
chronic renal failure. Nephron. Clinical 
Practice. 2003;93(4):c124-c130
[4] Grenom S, Lachepelle K, 
Marcil M, Omeroğlu A, Genest J, 
Varenes B. Surgical strategies for severe 
calcification of the aorta (porcelain aorta) 
in two patients with homozygous familial 
hypercholesterolemia. The Canadian 
Journal of Cardiology. 2007;23:1159-1161
[5] Schoen F, Cotran R. Blood vessels. In: 
Cotran R, Kumar V, Collıns T, editors. 
Robbins Pathological Basis of Disesase. 
6th ed. London: W.B. Saunders; 1999. 
pp. 493-541
[6] Allıson M, Criquıi M, Wriht C. 
Patterns and risk factors for 
systemic calcified atherosclerosis. 
Arteriosclerosis, Thrombosis, and 
Vascular Biology. 2004;24(2):331-336
[7] Reaven P, Saks J. Reduced coronary 
artery and abdominal calcification in 
Hispanics with type 2 diabetes. Diabetes 
Care. 2004;27(5):1115-1120
[8] Lee D, Joo H, Jung H, 
Lim D. Investigating potential mediator 
between statin and coronary 
artery calcification. PLoS One. 
2018;13(9):e0203702
[9] Belay T. Involvement of vitamin 
k-dependent proteins in vascular 
calcification. Journal of Cardiovascular 
Pharmacology and Therapeutics. 
2019;24(4):323-333
[10] Li N, Sanyour H, Remund T, 
Kelly P, et al. Vascular extracellular matrix 
and fibroblasts-coculture directed 
differentiation of human mesenchymal 
stem cells toward smooth muscle-like cells 
for vascular tissue engineering. Materials 
Science and Engineering: C. 2018;93:61-
69. DOI: 10.1016/j.msec.2018.07.061
[11] Huang H, Sun Z, Hill M, et al. 
A calcium medicated mechanism 
coordinating vascular smooth muscle 
cell adhesion during KCI activation. 
Frontiers in Physiology. 2018;9:a1810. 
DOI: 10.3389 phys.2018.01810
[12] Tani E. Molecular mechanisms 
involved in development of cerebral 
vasospasm. Neurosurgical Focus. 
2002;12:ECP1. DOI: 10.3171/
foc.2002.12.3.8
[13] Hop J, Rinkel G, Algra A, et al. Case-
fatality rates and functional outcome 
after subarachnoid hemorrhage: 
A systematic review. Stroke. 
1997;28:660-664
[14] Barret H, Van der Heiden K, Farel E, 
et al. Calcifications in atherosclerotic 
plaques and impact on plaques 
biomechanics. Journal of Biomechanics. 
2019;87:1-12
[15] Khalid N, Ahmad SA, Shlofmitz E. 
Pericardial Calcification. [Updated 2019 
Nov 14]. In: StatPearls [Internet]. Treasure 
Island (FL): StatPearls Publishing; Jan 
2019. Available from: https://www.ncbi.
nlm.nih.gov/books/NBK538342/
[16] Yuki K, Osamu J, Atsushi K, 
Manabu M, Yuto K, et al. Massive 
bioventricular myocardial calcification 
in a patient with fulminant myocarditis 
requiring ventricular assist device 
support. Internal Medicine. 
2019;58(9):1283-1286
[17] Loıch P, Olivier L, Jean R, 
Michel G, Didier C, Jean F. Coronary 
References
New Insight into Cerebrovascular Diseases - An Updated Comprehensive Review
8
artery calcification: From crystal to plaque 
rupture. Archives of Cardiovascular 
Diseases. 2017;110(10):550-561
[18] Zhang Y, Song L, Song Y, Xu L, 
Wang H, et al. Impact coronary artery 
lesion calcification on the long-term 
outcome of patients with coronary heart 
disease after percutaneous coronary 
intervention. Zhonghua Xin Xue Guan 
Bing Za Zhi. 2019;47(1):33-41
[19] Philippe B, Christo M, Evin Y. Mitral 
annular calcification mitral stenosis: 
Therapeutic challenges and 
considerations. Current Treatment 
Options in Cardiovascular Medicine. 
2019;21(4):19
[20] Mohammed H, Abdallah S, Mayra G, 
Charanjit R, Mackram E. Paravalvular 
leak repair after balloon-expandable 
transcatheter mitral valve implantation 
in mitral annular calcification: Early 
experience and lessons learned. 
Catheterization and Cardiovascular 
Interventions. 2019;94(5):764-772
[21] Viral M, Soy L. The genetic 
regulation of aortic valve development 
and calcific disease. Frontiers in 
Cardiovascular Medicine. 2018;5:162
[22] Anderson C, Rodriguez E, 
Kupson A. Delayed left ventricle-to-
right atrial fistula following aortic valve 
replacement. The Journal of Heart Valve 
Disease. 2012;21(3):364-365
[23] Christian B, Maki O, Gerhard S, 
Cladius J, Jurgen R, Hendrick T, et al. 
Degree of valve calcification in patients 
undergoing transfemoral transcatheter 
aortic valve implantation with and 
without balloon aortic valvuloplasty: 
Findings from the multicenter 
EASE-IT TF registry. Catheterization 
and Cardiovascular Interventions. 
2019;94(3):469-478
[24] Vernhet H, Torres G, Laharotte S, 
Tournut P, Bierme T, Froment S, et al. 
Spontaneous calcific cerebral 
emboli from calcified aortic valve 
stenosis. Journal of Neuroradiology. 
1993;20(1):19-23
[25] Rutkovskaya N, Kagan E, 
Kondyukova N, Kuzmina O, 
Barborash L. Prediction of risk of 
calcification of heart valve bioprostheses 
on the basis of comprehensive 
assessment of recipients clinical factors 
and their compliance with therapy. 
Kardiologiia. 2018;10:27-33
[26] Mauntner R, Phillips J. 
Atrioventricular and intraventricular 
conduction disturbance in aortic 
valvular disease. Southern Medical 
Journal. 1980;73(5):572-578
[27] Vosnakidis A, Polymeropoulos K, 
Zarogoulidis P, Zarifis I. Atrioventricular 
nodal dysfunction secondary to 
hyperparathyroidism. Journal of 
Thoracic Disease. 2013;5(3):E 90-E 92
[28] Isotalo P, Halil A, Green M, 
Tang A, Lach B, Veinot J. Metastatic 
calcification of the cardiac conduction 
system with heart block: An under-
reported entity in chronic renal failure 
patients. Journal of Forensic Sciences. 
2000;45(6):1335-1338
[29] Jayalath R, Mangan S, 
Golledge J. Aortic calcification. European 
Journal of Vascular and Endovascular 
Surgery. 2005;30:476-488
[30] Nıskanen L, Suhonen M, 
Sııtonen O, Lehtınen J. Aortic and 
lower limb artery calcification in type 
2 (non-insulin-dependent) diabetic 
patients and non-diabetic control 
subject. A five-year follow-up study. 
Atherosclerosis. 1990;84(1):61-71
[31] Wu X, Wang L, Zhong J, et al. 
Impact of intracranial artery 
calcification on cerebral hemodynamic 
changes. Neuroradiology. 
2018;60:357-363
9Vascular Calcifications
DOI: http://dx.doi.org/10.5772/intechopen.90287
[32] Erbay S, Han R, Baccei S, et al. 
İntracranial carotid artery calcification 
on head CT and its association with 
ischemic changes on brain MRI in 
patients presenting with stroke-like 
symptoms: Retrospective analysis. 
Neuroradiology. 2007;49:27-33
[33] Gade P, Tulamo R, Lee K, et al. 
Calcification in human intracranial 
aneurysms is highly prevalent 
and displays both atherosclerotic 
and nonatherosclerotic types. 
Arteriosclerosis, Thrombosis, and 
Vascular Biology. 2019;39:2157-2167. 
DOI: 10.1161//ATVBAHA.119.312922
[34] Chen Y, Wei X, Lu J, et al. 
Correlation between intracranial 
arterial calcification and imaging of 
cerebral small vessel disease. Frontiers 
in Neurology. 2019;10:426. DOI: 
10.3389/fneur.2019.00426
[35] Shammas NW, Chandra P, 
Brodmann M, Weinstock B, Sedillo G, 
Cawich I, et al. Acute and 30-day safety 
and effectiveness evaluation of 
Eximo Medical’s B-Laser™, a novel 
atherectomy device, in subjects affected 
with infrainguinal peripheral arterial 
disease: Results of the EX-PAD-03 
trial. Cardiovascular Revascularization 
Medicine. 29 Nov 2018. pii: S1553-
8389(18)30565-7. DOI: 10.1016/j.
carrev.2018.11.022. [Epub ahead of 
print]
[36] Price L, Faries P, Mckinsey J, 
Prakash K, Tang G, Kovacic J, et al. 
The epidemiology, pathophysiology, 
and novel treatment of calcific 
arterial disease. Surgical Technology 
International. 2019;34:351-358
[37] Shammas N, Chanda P, 
Brodman M, Weinstock B, Sedillo G, 
Cawich I, et al. Acute and 30-day safety 
and effectiveness evaluation of 
Eximo medical’s B-Laser™, a novel 
atherectomy device, in subjects 
affected with infrainguinal peripheral 
arterial disease. Result of the 
EX-PAD-03 trial. Cardiovascular 
Revascularization Medicine. 2018. PII: 
S1553-8389(18)30565-7
[38] Kukida M, Mogi M, Ken-No H, 
Tsukada K, Bai H, Shan B, et al. AT2 
receptor stimulation inhibits phosphate-
induced vascular calcification. Kidney 
International. 2019;95(1):138-148
[39] Liu L, Zeng P, Yang X, Duan Y, 
Zhang W, Ma C, et al. Inhibition of 
vascular calcification. Arteriosclerosis, 
Thrombosis, and Vascular Biology. 
2018;38(10):2382-2395
[40] Wasilewski G, Verloet M, 
Schurgers L. The bone-vasculature 
axis: Calcium supplementation and 
the role of vitamin K. Frontiers in 
Cardiovascular Medicine. 2019;6:6
[41] Gao Z, Li X, Miao S, Lun L. Impacts 
of parathyroidectomy on calcium 
and phosphorus metabolism 
disorder, arterial calcification and 
arterial stiffness in haemodialysis 
patients. Asian Journal of Surgery. 
2019;42(1):6-10
